These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 28452036)

  • 21. Heregulin and HER3 are prognostic biomarkers in oropharyngeal squamous cell carcinoma.
    Qian G; Jiang N; Wang D; Newman S; Kim S; Chen Z; Garcia G; MacBeath G; Shin DM; Khuri FR; Chen ZG; Saba NF
    Cancer; 2015 Oct; 121(20):3600-11. PubMed ID: 26195293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidermal growth factor receptor (EGFR) and vascular endothelial growth factor (VEGF) negatively affect overall survival in carcinoma of the cervix treated with radiotherapy.
    Gaffney DK; Haslam D; Tsodikov A; Hammond E; Seaman J; Holden J; Lee RJ; Zempolich K; Dodson M
    Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):922-8. PubMed ID: 12829126
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of the epidermal growth factor receptor (EGRF) and p53 in advanced head and neck squamous cell carcinoma patients treated with induction chemotherapy.
    Hitt R; Ciruelos E; Amador ML; Benito A; Sanchez JJ; Ballestin C; Cortes-Funes H
    Eur J Cancer; 2005 Feb; 41(3):453-60. PubMed ID: 15691646
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of p16 expression, nodal status, and smoking on oncologic outcomes of patients with head and neck unknown primary squamous cell carcinoma.
    Dixon PR; Au M; Hosni A; Perez-Ordonez B; Weinreb I; Xu W; Song Y; Huang SH; O'Sullivan B; Goldstein DP; de Almeida JR
    Head Neck; 2016 Sep; 38(9):1347-53. PubMed ID: 27002481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MiR-21 as prognostic biomarker in head and neck squamous cell carcinoma patients undergoing an organ preservation protocol.
    Arantes LM; Laus AC; Melendez ME; de Carvalho AC; Sorroche BP; De Marchi PR; Evangelista AF; Scapulatempo-Neto C; de Souza Viana L; Carvalho AL
    Oncotarget; 2017 Feb; 8(6):9911-9921. PubMed ID: 28039483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adjuvant stereotactic body radiotherapy±cetuximab following salvage surgery in previously irradiated head and neck cancer.
    Vargo JA; Kubicek GJ; Ferris RL; Duvvuri U; Johnson JT; Ohr J; Clump DA; Burton S; Heron DE
    Laryngoscope; 2014 Jul; 124(7):1579-84. PubMed ID: 24123056
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevated expression of iASPP in head and neck squamous cell carcinoma and its clinical significance.
    Liu Z; Zhang X; Huang D; Liu Y; Zhang X; Liu L; Li G; Dai Y; Tan H; Xiao J; Tian Y
    Med Oncol; 2012 Dec; 29(5):3381-8. PubMed ID: 22815155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comprehensive genomic profiling of head and neck squamous cell carcinoma reveals FGFR1 amplifications and tumour genomic alterations burden as prognostic biomarkers of survival.
    Dubot C; Bernard V; Sablin MP; Vacher S; Chemlali W; Schnitzler A; Pierron G; Ait Rais K; Bessoltane N; Jeannot E; Klijanienko J; Mariani O; Jouffroy T; Calugaru V; Hoffmann C; Lesnik M; Badois N; Berger F; Le Tourneau C; Kamal M; Bieche I
    Eur J Cancer; 2018 Mar; 91():47-55. PubMed ID: 29331751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical perineural invasion of the trigeminal and facial nerves in cutaneous head and neck squamous cell carcinoma: Outcomes and prognostic implications of multimodality and salvage treatment.
    Erkan S; Savundra JM; Wood B; Acharya AN; Rajan GP
    Head Neck; 2017 Jul; 39(7):1280-1286. PubMed ID: 28474414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced cell migration and apoptosis resistance may underlie the association between high SERPINE1 expression and poor outcome in head and neck carcinoma patients.
    Pavón MA; Arroyo-Solera I; Téllez-Gabriel M; León X; Virós D; López M; Gallardo A; Céspedes MV; Casanova I; López-Pousa A; Mangues MA; Quer M; Barnadas A; Mangues R
    Oncotarget; 2015 Oct; 6(30):29016-33. PubMed ID: 26359694
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ERCC1 protein, mRNA expression and T19007C polymorphism as prognostic markers in head and neck squamous cell carcinoma patients treated with surgery and adjuvant cisplatin-based chemoradiation.
    De Castro G; Pasini FS; Siqueira SA; Ferraz AR; Villar RC; Snitcovsky IM; Federico MH
    Oncol Rep; 2011 Mar; 25(3):693-9. PubMed ID: 21206986
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor epidermal growth factor receptor and EGFR PY1068 are independent prognostic indicators for head and neck squamous cell carcinoma.
    Wheeler S; Siwak DR; Chai R; LaValle C; Seethala RR; Wang L; Cieply K; Sherer C; Joy C; Mills GB; Argiris A; Siegfried JM; Grandis JR; Egloff AM
    Clin Cancer Res; 2012 Apr; 18(8):2278-89. PubMed ID: 22351687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of circulating tumor cells with podoplanin expression in patients with locally advanced or metastatic head and neck squamous cell carcinoma.
    Hsieh JC; Lin HC; Huang CY; Hsu HL; Wu TM; Lee CL; Chen MC; Wang HM; Tseng CP
    Head Neck; 2015 Oct; 37(10):1448-55. PubMed ID: 24844673
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidermal growth factor receptor is a prognosis predictor in patients with esophageal squamous cell carcinoma.
    Zhang W; Zhu H; Liu X; Wang Q; Zhang X; He J; Sun K; Liu X; Zhou Z; Xu N; Xiao Z
    Ann Thorac Surg; 2014 Aug; 98(2):513-9. PubMed ID: 24881860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low cytoplasmic and nuclear KPNA2 expression in radiotherapy-treated head and neck squamous cell cancer is associated with an adverse outcome.
    Erben PB; Brunner K; Hecht M; Haderlein M; Büttner-Herold M; Agaimy A; Fietkau R; Hartmann A; Distel LV
    Int J Clin Exp Pathol; 2015; 8(12):15814-24. PubMed ID: 26884852
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidermal Growth Factor Receptor (EGFR) and Keratin 5 (K5): Versatile Keyplayers Defining Prognostic and Therapeutic Sub-classes of Head and Neck Squamous Cell Carcinomas.
    Cimpean AM; Balica RA; Doros IC; Balica NC; Gaje PN; Popovici RA; Raica M
    Cancer Genomics Proteomics; 2016; 13(1):75-81. PubMed ID: 26708602
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FGFR1 Is a Potential Prognostic Biomarker and Therapeutic Target in Head and Neck Squamous Cell Carcinoma.
    Koole K; Brunen D; van Kempen PM; Noorlag R; de Bree R; Lieftink C; van Es RJ; Bernards R; Willems SM
    Clin Cancer Res; 2016 Aug; 22(15):3884-93. PubMed ID: 26936917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pretreatment albumin level predicts survival in head and neck squamous cell carcinoma.
    Lim WS; Roh JL; Kim SB; Choi SH; Nam SY; Kim SY
    Laryngoscope; 2017 Dec; 127(12):E437-E442. PubMed ID: 28561532
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative prognostic value of epidermal growth factor quantitative protein expression compared with FISH for head and neck squamous cell carcinoma.
    Pectasides E; Rampias T; Kountourakis P; Sasaki C; Kowalski D; Fountzilas G; Zaramboukas T; Rimm D; Burtness B; Psyrri A
    Clin Cancer Res; 2011 May; 17(9):2947-54. PubMed ID: 21355076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic impact of VEGF and FLT-1 receptor expression in patients with locally advanced squamous cell carcinoma of the head and neck.
    Seibold ND; Schild SE; Bruchhage KL; Gebhard MP; Noack F; Rades D
    Strahlenther Onkol; 2013 Aug; 189(8):639-46. PubMed ID: 23748230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.